COVID-19 exacerbating ESRD induced pericardial effusion requiring pericardial window: A case report.
COVID-19
Cardiac tamponade
ESRD
Pericardial window
Renal transplant
Journal
International journal of surgery case reports
ISSN: 2210-2612
Titre abrégé: Int J Surg Case Rep
Pays: Netherlands
ID NLM: 101529872
Informations de publication
Date de publication:
Aug 2023
Aug 2023
Historique:
received:
23
06
2023
revised:
19
07
2023
accepted:
23
07
2023
medline:
30
7
2023
pubmed:
30
7
2023
entrez:
29
7
2023
Statut:
ppublish
Résumé
Pericardial effusion can lead to cardiac tamponade requiring immediate management. Pericardial windows are an effective measure to surgically drain recurrent effusions. We present a case of a 53-year-old male with recurrent pericardial effusion secondary to ESRD and exacerbated by COVID-19 infection, describing the successful management of an uncommon clinical scenario. A sub-xiphoid pericardial window and right sided thoracostomy was performed. There are limited case reports highlighting recurrent pericardial effusion management, secondary to ESRD and COVID-19 in a post renal transplant patient, through a subxiphoid pericardial window. COVID-19 infection can exacerbate pericardial effusion in a patient with ESRD, post renal transplant. Preventing cardiac tamponade, a sub-xiphoid pericardial window remains an effective measure in treating recurrent pericardial effusion.
Identifiants
pubmed: 37515850
pii: S2210-2612(23)00694-6
doi: 10.1016/j.ijscr.2023.108565
pmc: PMC10407422
pii:
doi:
Types de publication
Case Reports
Langues
eng
Pagination
108565Informations de copyright
Copyright © 2023 The Authors. Published by Elsevier Ltd.. All rights reserved.
Déclaration de conflit d'intérêts
Declaration of competing interest No conflicts of interest.